SVA

Sinovac Biotech, Ltd
SVA

Overview Fund Activity
Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

29 hedge funds and large institutions have $48.4M invested in Sinovac Biotech, Ltd in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
–
Holders Change %
0%
% of All Funds
0.66%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
2
Reduced
12
Closed
5
Calls
$482K
Puts
$384K
Net Calls
+$98K
Net Calls Change
-$571K

Top Buyers

1
SSP
1
Sapphire Star Partners
Washington
$723K
2
YMRC
2
Yorktown Management & Research Company
Virginia
$482K
3
NA
3
Navellier & Associates
Nevada
$238K
4
Millennium Management
4
Millennium Management
New York
$76K
5
Morgan Stanley
5
Morgan Stanley
New York
$57K

Top Sellers

1
FIM
1
Freedom Investment Management
Connecticut
$312K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$18.9M
3
Deutsche Bank
3
Deutsche Bank
Germany
$547K
4
Invesco
4
Invesco
Georgia
$156K
5
SIM
5
Spark Investment Management
New York
$295K
Name Holding Trade Value Shares
Change 		Shares
Change %
FGAM
26
Financial Gravity Asset Management
Texas
$3K +$2.12K +325 +241%
GWM
27
Geneos Wealth Management
Colorado
$1K – – –
GC
28
Guggenheim Capital
Illinois
– -$179K -20,840 Closed
Two Sigma Investments
29
Two Sigma Investments
New York
– -$158K -18,302 Closed
PCM
30
Prelude Capital Management
New York
– -$86K -10,000 Closed
DAM
31
DLD Asset Management
New York
– -$86K -10,000 Closed
1
2